Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial - Guery, B; Menichetti, F; Anttila, VK (Lancet Infect Dis, 2018)